ASA Advises Monitoring for Exhaled Carbon Dioxide During Upper GI Procedures

The American Society of Anesthesiologists’ Ambulatory Surgical Care committee issued a statement, advising anesthesiologists to consider monitoring patients for exhaled carbon dioxide in procedures using propofol, especially involving the upper GI tract.

Advertisement

The ASA’s statement reads:

“Monitoring for exhaled carbon dioxide should be considered during endoscopic procedures in which sedation is provided with propofol alone or in combination with opioids and/or benzodiazepines, and especially during these procedures on the upper gastrointestinal tract. Careful attention to airway management must be provided during endoscopic retrograde cholangiopancreaticography (ERCP) procedures performed in the prone position where ventilatory monitoring, airway maintenance, and resuscitation may be especially difficult.”

Learn more about the ASA.

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Patient Safety & Outcomes

Advertisement

Comments are closed.